REST controls self-renewal and tumorigenic competence of human glioblastoma cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Conti, Luciano ^a   Crisafulli, Laura ^a   Caldera, Valentina ^b   Tortoreto, Monica ^c   Brilli, Elisa ^a   Conforti, Paola ^a   Zunino, Franco ^c   Magrassi, Lorenzo ^d   Schiffer, Davide ^b   Cattaneo, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Neuro bio oncology Center of Policlinico di Monza Foundation   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 124; PROTEIN REST; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; LIPOCORTIN 5; MICRORNA; MIRN124 MICRORNA, HUMAN; RE1 SILENCING TRANSCRIPTION FACTOR; RE1-SILENCING TRANSCRIPTION FACTOR; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL RENEWAL; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR CELL; ANALYSIS OF VARIANCE; ANIMAL; APOPTOSIS; CELL TRANSFORMATION; COLORIMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; COLORIMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 84862188342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038486     Document Type: Article

References (44)

1. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
2. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
3. Venere M, Fine HA, Dirks PB, Rich JN, (2011) Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia 59: 1148-1154.
4. Schoenherr CJ, Anderson DJ, (1995) Silencing is golden: negative regulation in the control of neuronal gene transcription. Curr Opin Neurobiol 5: 566-571.
5. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, et al. (1995) REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80: 949-957.
6. Chen ZF, Paquette AJ, Anderson DJ, (1998) NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat Genet 20: 136-142.
7. Jones FS, Meech R, (1999) Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues. Bioessays 21: 372-376.
8. Lunyak VV, Burgess R, Prefontaine GG, Nelson C, Sze SH, et al. (2002) Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298: 1747-1752.
9. Johnson DS, Mortazavi A, Myers RM, Wold B, (2007) Genome-wide mapping of in vivo protein-DNA interactions. Science 316: 1497-1502.
10. Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, et al. (2004) Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc Natl Acad Sci U S A 101: 10458-10463.
11. Qureshi IA, Mehler MF, (2009) Regulation of non-coding RNA networks in the nervous system-what's the REST of the story? Neurosci Lett 466: 73-80.
12. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G, (2005) REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121: 645-657.
13. Soldati C, Bithell A, Johnston C, Wong KY, Teng SW, et al. (2011) REST Couples Loss of Pluripotency with Neural Induction and Neural Differentiation. Stem Cells.
14. Mandel G, Fiondella CG, Covey MV, Lu DD, Loturco JJ, et al. (2011) Repressor element 1 silencing transcription factor (REST) controls radial migration and temporal neuronal specification during neocortical development. Proc Natl Acad Sci U S A 108: 16789-16794.
15. Gao Z, Ure K, Ding P, Nashaat M, Yuan L, et al. (2011) The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells. J Neurosci 31: 9772-9786.
16. Ooi L, Wood IC, (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8: 544-554.
17. Calderone A, Jover T, Noh KM, Tanaka H, Yokota H, et al. (2003) Ischemic insults derepress the gene silencer REST in neurons destined to die. J Neurosci 23: 2112-2121.
18. Garriga-Canut M, Schoenike B, Qazi R, Bergendahl K, Daley TJ, et al. (2006) 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci 9: 1382-1387.
19. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35: 76-83.
20. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, et al. (2005) A genetic screen for candidate tumor suppressors identifies REST. Cell 121: 837-848.
21. Reddy BY, Greco SJ, Patel PS, Trzaska KA, Rameshwar P, (2009) RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci U S A 106: 4408-4413.
22. Coulson JM, Edgson JL, Woll PJ, Quinn JP, (2000) A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res 60: 1840-1844.
23. Palm K, Metsis M, Timmusk T, (1999) Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat. Brain Res Mol Brain Res 72: 30-39.
24. Lawinger P, Venugopal R, Guo ZS, Immaneni A, Sengupta D, et al. (2000) The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells. Nat Med 6: 826-831.
25. Blom T, Tynninen O, Puputti M, Halonen M, Paetau A, et al. (2006) Molecular genetic analysis of the REST/NRSF gene in nervous system tumors. Acta Neuropathol 112: 483-490.
26. Zhang P, Lathia JD, Flavahan WA, Rich JN, Mattson MP, (2009) Squelching glioblastoma stem cells by targeting REST for proteasomal degradation. Trends Neurosci 32: 559-565.
27. Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, et al. (2009) Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 7: 157-167.
28. Gilbertson RJ, Rich JN, (2007) Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7: 733-736.
29. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, et al. (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580.
30. Huang Z, Wu Q, Guryanova OA, Cheng L, Shou W, et al. (2011) Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol 13: 142-152.
31. Westbrook TF, Hu G, Ang XL, Mulligan P, Pavlova NN, et al. (2008) SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452: 370-374.
32. Sun YM, Cooper M, Finch S, Lin HH, Chen ZF, et al. (2008) Rest-mediated regulation of extracellular matrix is crucial for neural development. PLoS One 3: e3656.
33. Kamal MM, Sathyan P, Singh SK, Zinn PO, Marisetty AL, et al. (2012) REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells 30(3): 405-414.
34. Zhang P, Pazin MJ, Schwartz CM, Becker KG, Wersto RP, et al. (2008) Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells. Curr Biol 18: 1489-1494.
35. Zhang P, Casaday-Potts R, Precht P, Jiang H, Liu Y, et al. (2011) Nontelomeric splice variant of telomere repeat-binding factor 2 maintains neuronal traits by sequestering repressor element 1-silencing transcription factor. Proc Natl Acad Sci U S A.
36. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
37. Wu J, Xie X, (2006) Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol 7: R85.
38. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
39. Fowler A, Thomson D, Giles K, Maleki S, Mreich E, et al. (2011) miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer 47: 953-963.
40. Conaco C, Otto S, Han JJ, Mandel G, (2006) Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A 103: 2422-2427.
41. Visvanathan J, Lee S, Lee B, Lee JW, Lee SK, (2007) The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev 21: 744-749.
42. Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, et al. (2011) Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 144: 703-718.
43. Sun Y, Pollard S, Conti L, Toselli M, Biella G, et al. (2008) Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci 38: 245-258.
44. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, et al. (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66: 10247-10252.